Spinal muscular atrophy

For family education. This resource is not an individual diagnosis or treatment plan. Discuss concerns with an appropriately qualified professional.

What it means

Spinal muscular atrophy (SMA) is a group of genetic conditions affecting motor nerve cells and causing muscle weakness. The most common form is related to SMN1. Severity and age of onset vary. Early identification is important because available disease-modifying treatment is time-sensitive and requires specialist care.

Causes and risk factors

Most childhood SMA results from changes in both copies of SMN1, reducing a protein needed by motor neurons. SMN2 and other factors influence the pattern, but do not predict every outcome. Other rarer forms of SMA have different genetic causes. Genetic counseling explains inheritance for the specific diagnosis.

Signs and everyday impact

Infants may show reduced movement, low tone, poor head control, weak cry, feeding fatigue, or breathing difficulty. Older children may have trouble standing, walking, or rising from the floor. Weakness is often more prominent near the trunk. A child can have substantial movement difficulties without impaired understanding.

Assessment and diagnosis

A pediatric neuromuscular team evaluates strength, reflexes, breathing, feeding, and development. Genetic testing usually confirms common SMN1-related SMA; other investigations depend on the findings. Newborn screening is available in some programs, but a previous screening result should not delay evaluation of concerning weakness.

Treatment and therapy

Specialists may offer medicines or gene-based treatments that improve SMN-related function, according to diagnosis, age, eligibility, local approval, and medical risks. Respiratory, nutritional, orthopedic, and rehabilitation care remain important. Physical and occupational therapy, equipment, and communication support help participation. Prompt referral should not wait for routine therapy to produce progress.

Support at home

Follow the respiratory, feeding, positioning, and illness plans. Allow rest and avoid overexertion. Ask about safe equipment and movement opportunities. Keep emergency information available and report changes in cough strength, intake, sleep, or movement promptly.

When to seek help

An infant with marked weakness, poor feeding, or reduced movement needs urgent assessment. Breathing difficulty, weak cough with illness, choking, or reduced responsiveness requires emergency care.

Questions for the care team

• Which genetic form has been confirmed?
• What time-sensitive treatment options and monitoring apply?
• What is our breathing, feeding, and illness plan?

Terms in plain language

• Motor neuron: a nerve cell that signals muscles.
• SMN: a protein important to motor neuron survival.
• Disease-modifying: addressing a biological process of the condition.

Podcast preparation

Use this resource to prepare a later episode: define the topic, discuss causes and signs, explain assessment, describe treatment and home supports, then close with urgent signs and a next step.

SMA treatment is not limited to exercises, and medical treatment does not remove the need for supportive care.

Verify current clinical guidance and obtain clinical review before public recording.

Sources

1. Spinal muscular atrophy: MedlinePlus Genetics - https://medlineplus.gov/genetics/condition/spinal-muscular-atrophy/
2. Spinal muscular atrophy: MedlinePlus Medical Encyclopedia - https://medlineplus.gov/ency/article/000996.htm
3. Hypotonia: MedlinePlus Medical Encyclopedia - https://medlineplus.gov/ency/article/003298.htm

Sources accessed 3 October 2026.